Xponance’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,951
Closed -$274K 1199
2021
Q4
$274K Buy
+2,951
New +$194K ﹤0.01% 1058
2021
Q3
Sell
-3,362
Closed -$229K 1255
2021
Q2
$229K Buy
+3,362
New +$219K ﹤0.01% 1140

Xponance's ARNA Position: Q1 2022 in Review

Xponance sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 2,951 shares — an estimated $274K sold.

Xponance first reported a position in ARNA in Q2 2021 and held it in 2 quarters. The position peaked at $274K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Xponance reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Xponance sold 2,951 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $274K.
  • Xponance first reported a position in Arena Pharmaceuticals Inc in Q2 2021 and held it in 2 quarters.
  • Xponance's Arena Pharmaceuticals Inc position peaked at $274K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Xponance's 13F filing for Q1 2022, filed 20 Apr 2022.